Suppr超能文献

清醒盐水负荷大鼠脑室内注射速激肽的肾脏效应:受体特征分析

Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization.

作者信息

Yuan Y D, Couture R

机构信息

Department of Physiology, Faculty of Medicine, Université de Montréal, Québec, Canada.

出版信息

Br J Pharmacol. 1997 Mar;120(5):785-96. doi: 10.1038/sj.bjp.0700972.

Abstract
  1. The effects of intracerebroventricularly (i.c.v.) injected substance P (SP), neurokinin A (NKA) and [MePhe7]neurokinin B (NKB) were investigated on renal excretion of water, sodium and potassium in the conscious saline-loaded rat. The central effects of [MePhe7]NKB were characterized with selective tachykinin antagonists for NK1 (RP 67580), NK2 (SR 48968) and NK3 (R 820) receptors. 2. Whereas SP or NKA (65 or 650 pmol) failed to modify the renal responses, [MePhe7]NKB (65-6500 pmol) produced dose-dependent and long-lasting (30-45 min) decreases in renal excretion of water (maximal reduction at 65 pmol: from 66.14 +/- 7.62 to 21.07 +/- 3.79 microliters min-1), sodium (maximal reduction at 65 pmol: from 10.19 +/- 2.0 to 1.75 +/- 0.48 mumol min-1) and potassium (maximal reduction at 65 pmol: from 4.31 +/- 1.38 to 0.71 +/- 0.27 mumol min-1). While 650 pmol [MePhe7]NKB elevated urinary osmolality, neither 65 pmol nor 6.5 nmol [MePhe7]NKB altered this parameter. 3. Both the antidiuresis and antinatriuresis induced by [MePhe7]NKB (65 pmol) were significantly blocked by the prior i.c.v. injection of R 820 (1.3 nmol, 5 min earlier), although the potassium excretion was only partially reduced. However, R 820 did not affect the antidiuresis and antinatriuresis elicited by endothelin-1 (1 pmol, i.c.v.). On its own, R 820 decreased renal potassium excretion with no effect on urinary osmolality and renal excretion of water and sodium. The i.c.v. co-injection of RP 67580 and SR 48968 (6.5 nmol each, 5 min earlier) failed to modify the renal responses to [MePhe7]NKB in a similar study. 4. The central effects of [MePhe7]NKB (65 pmol) on renal excretion were blocked by the prior i.v. administration of a linear peptide vasopressin V2 receptor antagonist (50 micrograms kg-1, 5 min earlier). 5. These results suggest that the central NK3 receptor, probably located in the hypothalamus, is implicated in the renal control of water and electrolyte homeostasis through the release of vasopressin in the conscious saline-loaded rat.
摘要
  1. 研究了脑室内(i.c.v.)注射P物质(SP)、神经激肽A(NKA)和[甲基苯丙氨酸7]神经激肽B(NKB)对清醒生理盐水负荷大鼠肾水、钠和钾排泄的影响。用NK1(RP 67580)、NK2(SR 48968)和NK3(R 820)受体的选择性速激肽拮抗剂对[甲基苯丙氨酸7]NKB的中枢作用进行了表征。2. 虽然SP或NKA(65或650皮摩尔)未能改变肾脏反应,但[甲基苯丙氨酸7]NKB(65 - 6500皮摩尔)使肾水排泄产生剂量依赖性且持久(30 - 45分钟)的减少(65皮摩尔时最大减少:从66.14±7.62降至21.07±3.79微升/分钟)、钠排泄减少(65皮摩尔时最大减少:从10.19±2.0降至1.75±0.48微摩尔/分钟)和钾排泄减少(65皮摩尔时最大减少:从4.31±1.38降至0.71±0.27微摩尔/分钟)。虽然650皮摩尔[甲基苯丙氨酸7]NKB升高了尿渗透压,但65皮摩尔和6.5纳摩尔[甲基苯丙氨酸7]NKB均未改变该参数。3. [甲基苯丙氨酸7]NKB(65皮摩尔)诱导的抗利尿和抗钠尿作用均被预先脑室内注射R 820(1.3纳摩尔,提前5分钟)显著阻断,尽管钾排泄仅部分减少。然而,R 820并不影响内皮素 - 1(1皮摩尔,脑室内注射)引起的抗利尿和抗钠尿作用。单独使用时,R 820减少肾钾排泄,对尿渗透压以及肾水和钠排泄无影响。在类似研究中,脑室内共同注射RP 67580和SR 48968(各6.5纳摩尔,提前5分钟)未能改变肾脏对[甲基苯丙氨酸7]NKB的反应。4. [甲基苯丙氨酸7]NKB(65皮摩尔)对肾排泄的中枢作用被预先静脉注射线性肽血管加压素V2受体拮抗剂(50微克/千克,提前5分钟)阻断。5. 这些结果表明,中枢NK3受体可能位于下丘脑,通过在清醒生理盐水负荷大鼠中释放血管加压素参与肾脏对水和电解质稳态的控制。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验